Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI) in surgery and medical device innovation. This partnership stems from a Memorandum of Understanding signed earlier this year, with further details unveiled at the World Congress of Endoscopic Surgery (WCES).

As surgical challenges evolve, AI-driven technologies are enabling surgeons with data-driven insights to deliver safer, personalised and better outcomes for patients. At the same time, these innovations support hospitals in providing more cost-effective care.

Under this two-phase, four-year program, the Genesis MedTech–NUHS AI Innovation Partnership adopts a design-led approach to translate unmet needs into clinically meaningful solutions. This partnership will include co-innovating AI projects in surgery, engaging NUHS clinicians to enable stronger alignment between product development and real-word clinical needs and establishing the "Genesis-NUHS AI Innovation and Surgical Training Lab".

"Innovation in healthcare happens where clinicians and engineers meet," said Warren Wang, Chairman & CEO, Genesis MedTech. "Our partnership with NUHS represents our commitment to advancing AI-powered surgical innovation — built around real clinical challenges, developed hand-in-hand with hospitals."

Adjunct Professor Ngiam Kee Yuan, Head of AI Office, NUHS, said, "By combining NUHS's clinical and academic excellence with Genesis MedTech's global innovation platform, we aim to accelerate AI adoption to improve surgical care for patients in Singapore and internationally." Adjunct Professor Ngiam is also a Senior Consultant and Head of the Division of General Surgery (Endocrine & Thyroid Surgery), Department of Surgery, National University Hospital.

The Genesis–NUHS AI Innovation Partnership represents a long-term commitment to advancing healthcare through AI and close clinician-industry collaboration, making surgery safer, smarter and more accessible to patients worldwide.